{"slideshow_credits": null, "snippet": "The move by the Food and Drug Administration represents a victory for the manufacturer and others who feared feeding street demand for the powerful painkiller.", "abstract": "Food and Drug Administration says that it will not approve generic versions of the powerful narcotic OxyContin, painkiller that symbolized a decade-long epidemic of prescription abuse; decision is victory for those saying generic versions would feed street demand, but will also likely result in higher prices.", "section_name": "Business Day", "print_page": "1", "document_type": "article", "byline": {"person": [{"firstname": "Barry", "role": "reported", "lastname": "MEIER", "rank": 1, "organization": ""}], "original": "By BARRY MEIER", "contributor": ""}, "web_url": "http://www.nytimes.com/2013/04/17/business/fda-bars-generic-oxycontin.html", "lead_paragraph": "The move by the Food and Drug Administration represents a victory for the manufacturer and others who feared feeding street demand for the powerful painkiller.", "headline": {"main": "F.D.A. Bars Generic OxyContin", "print_headline": "F.D.A. Bars Generic OxyContin"}, "_id": "516dd43bcf28d02a61000e8c", "word_count": "725", "multimedia": [{"height": 126, "url": "images/2013/04/17/business/17drug-pic/17drug-pic-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2013/04/17/business/17drug-pic/17drug-pic-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 399, "url": "images/2013/04/17/business/17drug-pic/17drug-pic-articleLarge.jpg", "legacy": {"xlarge": "images/2013/04/17/business/17drug-pic/17drug-pic-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "399"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2013/04/17/business/17drug-pic/17drug-pic-thumbStandard.jpg", "legacy": {"thumbnail": "images/2013/04/17/business/17drug-pic/17drug-pic-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2013-04-17T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Drug Abuse and Traffic", "name": "subject", "is_major": "Y", "rank": "1"}, {"value": "OxyContin (Drug)", "name": "subject", "is_major": "Y", "rank": "2"}, {"value": "Generic Brands and Products", "name": "subject", "is_major": "Y", "rank": "3"}, {"value": "Purdue Pharma", "name": "organizations", "is_major": "Y", "rank": "4"}, {"value": "Food and Drug Administration", "name": "organizations", "is_major": "N", "rank": "5"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "N", "rank": "6"}], "blog": [], "subsection_name": null, "type_of_material": "News"}